Black Rock Inc. Cue Biopharma, Inc. Transaction History

Black Rock Inc.

$4.35 Trillion
Q2 2024

A detailed history of Black Rock Inc. transactions in Cue Biopharma, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 756,736 shares of CUE stock, worth $582,686. This represents 0.0% of its overall portfolio holdings.

Number of Shares

756,736

Previous 2,244,103 66.28%

Holding current value

$582,686

Previous $4.24 Million 77.88%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$1.24 - $2.18 $1.84 Million - $3.24 Million	-1,487,367 Reduced 66.28%	756,736 $938,000
Q1 2024 May 10, 2024	SELL	$1.77 - $3.09 $167,551 - $292,505	-94,662 Reduced 4.05%	2,244,103 $4.24 Million
Q4 2023 Feb 13, 2024	BUY	$1.72 - $3.1 $360,881 - $650,426	209,815 Added 9.86%	2,338,765 $6.17 Million
Q3 2023 Nov 13, 2023	BUY	$2.23 - $4.69 $140,213 - $294,888	62,876 Added 3.04%	2,128,950 $4.9 Million
Q2 2023 Aug 11, 2023	BUY	$3.11 - $4.91 $4.36 Million - $6.88 Million	1,401,648 Added 210.96%	2,066,074 $7.54 Million
Q1 2023 May 12, 2023	SELL	$2.41 - $3.74 $90,989 - $141,203	-37,755 Reduced 5.38%	664,426 $2.37 Million
Q4 2022 Feb 13, 2023	SELL	$2.39 - $3.95 $182,899 - $302,281	-76,527 Reduced 9.83%	702,181 $2 Million
Q3 2022 Nov 14, 2022	SELL	$2.23 - $3.37 $118,673 - $179,341	-53,217 Reduced 6.4%	778,708 $1.74 Million
Q2 2022 Aug 12, 2022	SELL	$2.49 - $5.92 $3.86 Million - $9.17 Million	-1,549,342 Reduced 65.06%	831,925 $2.07 Million
Q1 2022 May 12, 2022	BUY	$4.41 - $12.28 $401,301 - $1.12 Million	90,998 Added 3.97%	2,381,267 $11.6 Million
Q4 2021 Feb 10, 2022	BUY	$10.86 - $17.85 $1.41 Million - $2.32 Million	129,811 Added 6.01%	2,290,269 $25.9 Million
Q3 2021 Nov 09, 2021	BUY	$10.06 - $15.3 $117,299 - $178,398	11,660 Added 0.54%	2,160,458 $31.5 Million
Q2 2021 Aug 11, 2021	BUY	$10.9 - $14.53 $23.4 Million - $31.2 Million	2,148,798 New	2,148,798 $25 Million

Others Institutions Holding CUE

# of Institutions

Shares Held

17.7M

Call Options Held

Put Options Held

View Full List

About Cue Biopharma, Inc.

Ticker CUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,381,700
Market Cap $27.2M
Description
Cue Biopharma, Inc., a clinical-stage biopharmaceutical company, develops biologic drugs for the selective modulation of the human immune system to treat a range of cancers, chronic infectious diseases, and autoimmune disorders. Its lead drug candidate is CUE-101, a fusion protein biologic that is in Phase 1b clinical trial designed to target an...

More about CUE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account